Results 41 to 50 of about 568,486 (233)
Idiopathic thrombocytopenic purpura and its fundus features in a patient with diabetes mellitus
Indian Journal of Ophthalmology, 2020 In this case report, we present a patient with thrombocytopenia secondary to idiopathic thrombocytopenic purpura (ITP), whose fundus appearance had features of diabetic retinopathy with macular edema.
R Rajesh +2 more
doaj +1 more source
Intravitreal Therapy for Diabetic Macular Edema: An Update
Journal of Ophthalmology, 2021 Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight‐threatening condition, it is also among the most accessible to treatment.
C. Furino +3 more
semanticscholar +1 more source
Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography [PDF]
Egyptian Journal of Medical Research, 2022 Background: Diabetic macular edema (DME) can occur at any stage of non-proliferative and proliferative diabetic retinopathy. It is characterized by a swelling of the macular area that normally accounts for high-resolution visual acuity (VA), and DME ...
Hossam El din Khalil +2 more
doaj +1 more source
Corticosteroids for diabetic macular edema
Taiwan Journal of Ophthalmology, 2019 Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME. VEGF inhibitors and corticosteroids have all been used successfully in the management of DME.
Jorge Chawan-Saad +3 more
openaire +3 more sources
Central Macular Thickness in Diabetic Macular Edema
Acta Endocrinologica (Bucharest), 2020 Retinal microvascular dysfunction differs in macular edema lesions in the two eyes of the same patient with diabetic retinopathy.To evaluate the relationship between central macular thickness (CMT) and metabolic/systemic factors including anthropometric and laboratory findings, in patients with regressed diabetic retinopathy and a history of pars plana
Güngel, H. +4 more
openaire +3 more sources
New Insights in Resistant Diabetic Macular Edema
Ophthalmologica, 2021 Diabetic macular edema (DME) is the most common cause of vision loss in diabetic eyes, and due to the rapid rise in the number of diabetic patients, the treatment burden has increased exponentially.
Dante Akira Kondo Kuroiwa +2 more
semanticscholar +1 more source
Enzymatic vitreolysis for the treatment of tractional diabetic macular edema
Therapeutic Advances in Ophthalmology, 2019 Background: A new approach to address focal vitreomacular adhesion in patients with diabetic macular edema may control and stabilize diabetic macular edema with fewer anti-vascular endothelial growth factor injections.
Bernardete Pessoa +7 more
doaj +1 more source
The role of inflammation and neurodegeneration in diabetic macular edema
Therapeutic Advances in Ophthalmology, 2021 The pathogenesis of diabetic macular edema (DME) is complex. Persistently high blood glucose activates multiple cellular pathways and induces inflammation, oxidation stress, and vascular dysfunction.
V. Starace +8 more
semanticscholar +1 more source
A Case of Diabetic Macular Edema with Prominent Chorioretinal Folds
Case Reports in Ophthalmology, 2017 Purpose: To report a case of diabetic macular edema with prominent chorioretinal folds. Case Report: This study involved a 55-year-old male with untreated bilateral diabetic retinopathy who had undergone cataract surgery at another clinic. Following that
Takaki Sato +9 more
doaj +1 more source
A study of therapeutic effects of 670 nm irradiation in different types of diabetic macular edema
Biomedical Photonics, 2021 The purpose of this study was to investigate the therapeutic effects of 670 nm irradiation in patients with diabetic macular edema. In several studies, positive effects of red/near-infrared irradiation showed in a range of ocular diseases such as macular
S. Ramin, M. Ahadi, A. Ebrahimi
doaj +1 more source